Manish A Shah
Manish A Shah
Weill Cornell, New York Hospital, Chair Solid Tumor Service, Co-Dir Cntr for Advanced Digestive Care
Verified email at - Homepage
Cited by
Cited by
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
ME MacDonald, CM Ambrose, MP Duyao, RH Myers, C Lin, L Srinidhi, ...
Cell 72 (6), 971-983, 1993
Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial
CS Fuchs, T Doi, RW Jang, K Muro, T Satoh, M Machado, W Sun, SI Jalal, ...
JAMA oncology 4 (5), e180013-e180013, 2018
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry
KY Chung, J Shia, NE Kemeny, M Shah, GK Schwartz, A Tse, A Hamilton, ...
Journal of clinical oncology 23 (9), 1803-1810, 2005
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study
A Ohtsu, MA Shah, E Van Cutsem, SY Rha, A Sawaki, SR Park, HY Lim, ...
J Clin Oncol 29 (30), 3968-3976, 2011
Targeting the cell cycle: a new approach to cancer therapy
GK Schwartz, MA Shah
Journal of clinical oncology 23 (36), 9408-9421, 2005
Oesophageal cancer
EC Smyth, J Lagergren, RC Fitzgerald, F Lordick, MA Shah, P Lagergren, ...
Nature reviews Disease primers 3 (1), 1-21, 2017
Gastric cancer epidemiology and risk factors
DE Guggenheim, MA Shah
Journal of surgical oncology 107 (3), 230-236, 2013
Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer
T Kojima, MA Shah, K Muro, E Francois, A Adenis, CH Hsu, T Doi, ...
Journal of Clinical Oncology 38 (35), 4138-4148, 2020
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial
E Van Cutsem, S de Haas, YK Kang, A Ohtsu, NC Tebbutt, JM Xu, ...
Journal of clinical oncology 30 (17), 2119-2127, 2012
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
JM Sun, L Shen, MA Shah, P Enzinger, A Adenis, T Doi, T Kojima, ...
The Lancet 398 (10302), 759-771, 2021
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma
MA Shah, RK Ramanathan, D Ilson, ...
Journal of Clinical Oncology 24 (33), 5201-5206, 2006
Chemotherapy use, performance status, and quality of life at the end of life
HG Prigerson, Y Bao, MA Shah, ME Paulk, TW LeBlanc, BJ Schneider, ...
JAMA oncology 1 (6), 778-784, 2015
Cell cycle-mediated drug resistance: an emerging concept in cancer therapy
MA Shah, GK Schwartz
Clinical cancer research 7 (8), 2168-2181, 2001
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an …
PC Thuss-Patience, MA Shah, A Ohtsu, E Van Cutsem, JA Ajani, H Castro, ...
The lancet oncology 18 (5), 640-653, 2017
Efficacy and safety of pembrolizumab for heavily pretreated patients with advanced, metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: the phase 2 KEYNOTE …
MA Shah, T Kojima, D Hochhauser, P Enzinger, J Raimbourg, ...
JAMA oncology 5 (4), 546-550, 2019
Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram
VE Strong, KY Song, CH Park, LM Jacks, M Gonen, M Shah, DG Coit, ...
Annals of surgery 251 (4), 640-646, 2010
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised …
J Tabernero, PM Hoff, L Shen, A Ohtsu, MA Shah, K Cheng, C Song, ...
The Lancet Oncology 19 (10), 1372-1384, 2018
Locally advanced, unresectable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline
EP Balaban, PB Mangu, AA Khorana, MA Shah, S Mukherjee, CH Crane, ...
J Clin Oncol 34 (22), 2654-2668, 2016
Infection of Orthopedic Prostheses after Staphylococcus aureus Bacteremia
DR Murdoch, SA Roberts, VG Fowler Jr, MA Shah, SL Taylor, AJ Morris, ...
Clinical infectious diseases 32 (4), 647-649, 2001
Metastatic pancreatic cancer: American Society of Clinical Oncology clinical practice guideline
DPS Sohal, PB Mangu, AA Khorana, MA Shah, PA Philip, EM O’Reilly, ...
Journal of Clinical Oncology 34 (23), 2784, 2016
The system can't perform the operation now. Try again later.
Articles 1–20